News for ROSSARI BIOTECH LIMITED (ROSSARI.BO)

Mumbai-based Gem Aromatics, a manufacturer of specialty ingredients, has filled its draft papers with Sebi to raise funds through an initial public offer.

Gem Aromatics Ltd. has filed its Draft Red Herring Prospectus with the Securities and Exchange Board of India to raise up to Rs 175 crore through an initial public offering. The initial public offering will include a fresh issuance of equity shares worth Rs 175 crore, along with an offer-for-sale of 89.24 lakh shares by promoters and investors.

Oct 21, 2024 / 11:30AM GMTOperator Ladies and gentlemen, good day and welcome to the Rossari Biotech Limited earnings conference call. As a reminder, all partic

Q2 Results Today: From established names like HDFC Bank and Tech Mahindra to emerging players like Achyut Healthcare and Nutraplus India, investors will have a plethora of financial statements to analyze.

Apr 30, 2024 / 10:30AM GMTOperator Ladies and gentlemen, good day and welcome to the Rossari Biotech Limited earnings conference call. (Operator Instructions) P

YES Bank, Ola Electric, SBI, Tata Steel, Hindustan Zinc, PNB, SpiceJet, Glenmark Pharma, Max India and more may remain under the spotlight before the opening bell on Friday, August 16.

Jul 22, 2024 / 11:30AM GMTOperator Ladies and gentlemen, good day and welcome to the Rossari Biotech Limited earnings conference call. (Operator Instructions) P

While margins have dipped from around 22 per cent to 17 per cent during FY2021-24, they are expected to improve from FY26 onwards

Jan 23, 2024 / 10:30AM GMTOperator Ladies and gentlemen, good day and welcome to the Rossari Biotech Limited earnings conference call. (Operator instructions) I

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 925 in its research report dated January 25, 2024.

Q3 Results today: Major banks like ICICI Bank, IDBI Bank, IDFC First Bank, Kotak Mahindra Bank, and Union Bank of India will release their Q3 results, among 40 companies.

Nifty futures on the NSE International Exchange traded 24 points, or 0.11 per cent, lower at 21,697.50, hinting at a positive start for the domestic market on Saturday.

A long build-up was seen in 78 stocks, which included IRCTC, Can Fin Homes, Atul, ONGC, and Titan Company.

A short build-up was seen in 55 stocks including LTIMindtree, HDFC Bank, ICICI Prudential Life Insurance Company, Max Financial Services Company, and IndiaMART InterMESH.

A short build-up was seen in 71 stocks, including Astral, Indraprastha Gas, Dr Lal PathLabs, Ipca Laboratories and Oracle Financial

There was no major jump in investor wealth, possibly because only select large-cap stocks rallied.

Based on the OI percentage, a short build-up was seen in 58 stocks including Birlasoft, Adani Ports, ACC, Coromandel International, and HDFC Life Insurance Company.

The number of scrips at lower circuit clearly outnumbered number of stocks at upper circuit. And the similar kind of situation was seen in 52-week high and low segments.

Since October, FIIs have sold over Rs 3.68 lakh crore, while DIIs have net bought Rs 2.8 lakh crore worth of shares. This risk-off sentiment is largely thanks to inflation concerns, which have forced central banks in many countries to raise policy rate